Cargando…
Unbiased Functional Proteomics Strategy for Protein Kinase Inhibitor Validation and Identification of bona fide Protein Kinase Substrates: Application to Identification of EEF1D as a Substrate for CK2
[Image: see text] Protein kinases have emerged as attractive targets for treatment of several diseases prompting large-scale phosphoproteomics studies to elucidate their cellular actions and the design of novel inhibitory compounds. Current limitations include extensive reliance on consensus predict...
Autores principales: | Gyenis, Laszlo, Duncan, James S., Turowec, Jacob P., Bretner, Maria, Litchfield, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2011
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208357/ https://www.ncbi.nlm.nih.gov/pubmed/21936567 http://dx.doi.org/10.1021/pr2008994 |
Ejemplares similares
-
What Are the bona fide GSK3 Substrates?
por: Sutherland, Calum
Publicado: (2011) -
A bona fide MAP kinase
por: Oldach, Laurel
Publicado: (2022) -
The Bona Fide Nurse
Publicado: (1919) -
An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection
por: Brennick, Cory A., et al.
Publicado: (2021) -
Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α′: implications for pathological roles of CK2 in promoting cancer cell survival
por: Turowec, Jacob P., et al.
Publicado: (2013)